Current Liabilities تغيير تاريخ
AbbVie USD 34.77B 2.53B 2023-09
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amgen USD 18.39B 1.44B 2023-12
Biogen USD 3.43B 1.59B 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Cytokinetics USD 102.68M 24.96M 2023-12
Dynavax Technologies USD 62.2M 7.93M 2023-12
Enanta Pharmaceuticals USD 62.79M 5.4M 2023-09
Exelixis USD 376.82M 37.2M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Incyte USD 1.24B 115.7M 2023-12
Intra Cellular Therapies USD 123.54M 20.45M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Repligen USD 363.36M 10.22M 2023-09
Rigel Pharmaceuticals USD 48.27M 4.25M 2023-09
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09
Xoma USD 10.33M 3.25M 2023-09



Neurocrine Biosciences المديونيات المتداولة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.